Banque Transatlantique’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,824
Closed -$332 257
2025
Q1
$332 Buy
+1,824
New +$332 ﹤0.01% 1006